The Health Innovations Conference will create opportunities to initiate collaborative efforts in Health Innovation with representatives from the National Institute of Allergy and Infectious Diseases (NIAID), Clarke Group, CryptoSavannah, Case Hospital, Centers for Diseases Control and Prevention (CDC), United States Agency for International Development (USAID), Andela Uganda and Janssen, the Pharmaceutical Companies of Johnson and Johnson. It will be attended by members of various fields such as innovations, health, last mile health and bioinformatics.
On October 3, 2017 in Johannesburg South Africa, the European & Developing Countries Clinical Trials Partnership (EDCTP) launched an Alumni network whose goal is to foster Excellence and Collaboration in the next generation of researchers.
This years’ 9th International Aids Society (IAS) Conference on HIV Science (IAS 2017) is taking place at Palais des Congrès in Paris, France from July 23 to July 26, 2017. It is with great pleasure that I introduce you to the following staff who are representing the Infectious Diseases Institute (IDI), College of Health Sciences, Makerere University at this years’ conference:
On June 28 in Masindi district and on June 29, 2017 in Hoima district, the Infectious Diseases Institute (IDI) organized and held the second Annual Performance Review meeting for its Western Region Comprehensive HIV/AIDS project funded by the Centres for Disease Control and Prevention (CDC).
Tuberculosis (TB) is one of the leading infectious killer diseases worldwide, taking over 1.5 million lives per year. Treatment of TB patients lasts at least six months and can cause serious side effects making it difficult for patients to adhere.